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Expression of poliovirus protein 2B in mammalian cells inhibits protein secretion and increases the susceptibility of the 
cells to hygromycin B, consistent with the increase in plasma membrane permeability seen during poliovirus infection (J. 
R. Doedens and K. Kirkegaard, EMBO J. 14, 894-907, 1995). We report here that expression of protein 2B of the closely 
related coxsackie B3 virus (CBV3) leads to the same biochemical alterations. Analysis of several mutant CBV3 2B proteins 
that contain mutations in a predicted cationic amphipathic a-helix {F. J. M. van Kuppeveld, J. M. D. Gaiama, J. Zoll, P. J. J. C. 
van den Hurk, and W. J. G. Melchers, J. Virol. 70, 3876-3886, 1996) demonstrated that the integrity of this domain is crucial 
for both biochemical functions of 2B. Mutations in a second hydrophobic domain (F. J. M. van Kuppeveld, J. M. D. Gaiama, 
J. Zoll, and W. J. G. Melchers, J. Virol. 69, 7782-7790, 1995), on the other hand, are more disruptive to the ability of CBV3 
2B to inhibit protein secretion than to increase membrane permeability. Therefore, inhibition of protein secretion is not 
merely a consequence of the membrane changes that increase uptake of hygromycin B. The existence of mutations that 
interfere with virus growth but do not impair the ability of 2B to inhibit protein secretion or increase membrane permeability 
argues for additional functions of protein 2B. © 1997 Academic Press
INTRODUCTION
The genus Enterovirus consists of the poiioviruses, 
coxsackieviruses, echoviruses, and several enterovirus 
serotypes. Enteroviruses, like other picornaviruses, are 
small nonenveloped viruses which contain a 7.5-kb sin­
gle-stranded RNA molecule of positive polarity that is 
translated into a large polyprotein (Jang et aL, 1989; Pel­
letier and Sonenberg, 1988). This polyprotein is pro­
cessed by viraily encoded proteinases to the P1 region 
proteins, which form the viral capsid, and the P2 and P3 
region proteins, most of which are required for viral RNA 
(vRNA) replication (reviewed in Wimmer e ta i,  1993). The 
P2 region proteins have also been implicated in the struc­
tural organization of viral replication complexes and in 
the induction of several of the morphological and bio* 
chemical alterations that occur during infection. Protein 
2A is a proteinase that, in addition to cleaving the viral 
polyprotein, induces the cleavage of the 220-kDa compo­
nent of initiation factor elF-4F (Kraussiich et aL, 1987), 
implicated in the inhibition of translation of cellular 
mRNAs (Ehrenfeld, 1982; Etchison et aL, 1982). Protein 
2BC expression can induce the formation of membrane 
vesicles (Barco and Carrasco, 1995; Bienz et a)., 1983) 
and therefore may be the viral protein responsible for
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the generation of the small membrane vesicles on which 
vRNA replication takes place (Bienz et aL, 1983, 1987, 
1990, 1994). Protein 2C is a small NTPase with RNA 
binding properties (Mirzayan and Wimmer, 1994; Rodri­
guez and Carrasco, 1993), located at the cytoplasmic 
surface of the virus-induced membrane vesicles where 
it may be involved in attaching the vRNA to the membra­
nous replication complex (Bienz et aL, 1987, 1990, 1994).
Recently it was found that the expression of poliovirus 
protein 2B or 2BC results in two of the major biochemical 
alterations that occur during enterovirus infection: the 
inhibition of protein secretion (Doedens and Kirkegaard, 
1995) and the permeabilization of the plasma membrane 
(Benedetto et aL, 1980; Doedens and Kirkegaard, 1995). 
The relevance of these activities to the viral life cycle 
remains to be elucidated. The required residues and the 
mechanism of induction of these alterations are also un­
known. The finding that protein 2B permeabilizes cellular 
membranes in both mammalian cells and Escherichia 
coll (Lama and Carrasco, 1992) suggests that it may func­
tion as an ionophore or otherwise disrupt membrane 
function. Proteins that display such properties often con­
tain cationic amphipathic a-helical motifs (Bernheimer 
and Rudy, 1986; Eisenberg et aL, 1984; Segrest et aL, 
1990). Enterovirus 2B proteins all contain two hydropho­
bic domains, the more NH2-terminal of which is predicted 
to form a cationicamphipathica;-helix(Fig. 1). Mutational 
analysis of coxsackie B3 virus (CBV3) protein 2B argued 
that the cationic and amphipathic character of the pre­
dicted a-helix was indeed required for the function of 2B 
in vRNA replication and virus growth (van Kuppeveld et
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aL, 1996a). Mutational analysis of the second hydropho­
bic domain of CBV3 protein 2B demonstrated that muta­
tions that caused severe increases or decreases in the 
hydrophobic character of the domain also impaired the 
function of protein 2B in the viral replicative cycle (van
Kuppeveld et aL, 1995).
Here we report that CBV3 protein 2B, like poiiovirus
protein 28, is able to inhibit transport through the cellular 
secretory pathway and to modify the susceptibility of 
cells to hygromycin B, a translation inhibitor that normally 
enters cells poorly, in the absence of other viral proteins. 
Analysis of the activities of several mutant CBV3 2B pro­
teins (Fig. 1) in protein secretion inhibition and increased 
susceptibility to hygromycin B suggests that these two 
activities are separate functions of protein 2B rather than 
that one of these effects is the consequence of the other. 
Furthermore, the results indicate that the predicted cat­
ionic amphipathic a-helix is involved in both the inhibition 
of protein secretion and the permeabilizing activity, 
whereas mutation of the second hydrophobic domain 
has a greater effect on the secretion inhibition function.
MATERIALS AND METHODS 
Cells, antibodies, and reagents
COS-1 cells were grown as described (Doedens and 
Kirkegaard, 1995. Affinity-purified rabbit polyclonal anti­
body to alpha-1 protease inhibitor (A1P1) was obtained 
from Oswald Pfenniger and Jerry Brown (University of 
Colorado Health Sciences Center). Hygromycin B was 
from Boehringer Mannheim. Fixed Staphylococcus 
aureus cells for collecting immune complexes were ob­
tained from Gibco-BRL.
Construction of plasmids
The dicistronic plasmid p2BNCa6 containing the po­
iiovirus 2B coding region as the first cistron and the 
A1PI coding region as the second cistron has been 
described previously (Doedens and Kirkegaard, 1995). 
pC2Ba6, containing the CBV3 2B sequence upstream 
of A1PI, was constructed by PCR amplification of the 
CBV3 2B coding sequence from pCB3/T7 (Klump et aL, 
1990). The oligonucleotide primers, 5'-GCAATGTCG-
ACCATGGGAGTGAAGGACTATGTG-3' and 5'-AAG- 
CCACCCGGGCTATTGGCGTTCAGCCATAGG-3', intro­
duced a Sal I site and an initiation codon upstream of 
the CBV3 2B coding region and a stop codon and a 
SmaI site downstream of the 2B coding region. The 
327-bp amplified fragment was cut with Sal\ and Sma\ 
and cloned into pLINKo^, a plasmid containing Sail 
and Sma I sites upstream of the poiiovirus 5'-noncod- 
ing region and the A1PI coding region (Doedens and 
Kirkegaard, 1995). The 2B coding region of the mutant 
pCB3/T7 plasmids carrying mutations in either the hy­
drophobic domain (van Kuppeveld et aL, 1995) or the
amphipathic a-hellx (van Kuppeveld et aL, 1996a) of 
protein 2B was amplified with the same primers. Ampli­
fied products were cut with Spe i and Sma I and cloned 
into pC2Ba6 from which the corresponding fragment 
was deleted. The 2B coding sequence of all constructs 
was confirmed by sequence analysis.
4
Secretion assays
COS-1 cells growing on 60-mm dishes were trans­
fected using a standard calcium phosphate method (Au- 
subel et aL, 1990). All labelings were performed 2 days 
posttransfection. To radiolabel cells with [35S]methionine, 
transfected COS-1 cells were washed with phosphate- 
buffered salt solution (PBS) and Incubated in 1 ml of 
methionine-free DMEM supplemented with 50 ¿/Ci of 
[35S]methionine (Expre35S35S protein labeling mix, New 
England Nuclear) for 30 min. Following labeling, the cells 
were washed with PBS and placed in 1 ml fresh medium 
containing 0.23 m/Vf unlabeled methionine for 2 hr. At the 
end of the chase period, the culture medium was re­
moved and saved for further analysis. Cells were har­
vested by scraping into 0.5 ml PBS at 4°. The cells were 
pelleted by centrifugation at 300 g for 5 min and resus­
pended in 200 of PBS containing 1% Triton X-100, 0,5% 
sodium deoxycholate, and 1 mM  phenylmethylsulfonyl 
fluoride at 4° After 30 min on ice, detergent-insoluble 
material was pelleted in a microcentrifuge, and the su- 
pernatants were transferred to fresh tubes.
Immunoprecipitation of A1PI
Rabbit polyclonal antibody directed against A1PI was 
diluted in PBS containing 1% Triton X-100, 0.5% sodium 
deoxycholate, 0.5% SDS, and 1% bovine serum albumin. 
An equal volume of antibody dilution was added to each 
lysate sample to be precipitated. Two hundred microliters 
of antibody dilution was added to each 1-ml sample of 
culture supernatant. Immune precipitations were then in­
cubated for 2 hr on Ice, and antibody-antigen complexes 
were collected by incubation with fixed S. aureus cells. 
The cells and bound immune complexes were washed 
three times in ice-cold PBS containing 1% Triton X-100,
0.5% deoxycholate, and 1% SDS. Immunoprecipitated A1PI 
from cell lysates and culture supernatants was then dis­
played by SDS-PAGE and quantified on a phosphorim- 
ager (Molecular Dynamics). Relative amounts of A1PI se­
cretion were determined from the ratio of A1PI detected 
in the supernatant to that detected In the cell extract. This 
value was adjusted to 1.0 for cells expressing A1PI alone 
with no 2B protein, and the ratios for cells transfected with 
wild-type and mutant 2B proteins were normalized.
Hygromycin B sensitivity of transfected cells
Sensitivity of transfected COS-1 cells to hygromycin B 
was determined as described previously (Doedens and 
Kirkegaard, 1995) except that the labeling period was
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FIG. 1, Sequences of wild-type and mutant 2B proteins used in this study. Alignment of the om ple te  amino acid sequences of poliovirus type 
1 Mahoney and coxsackie B3 virus (CBV3) Is shown in the top panel. Numbering is with respe ;t to CBV3 2B protein. Solid lines indicate amino 
acid identity, colons ind icate ‘similarity, dashes indicate gaps in the alignment. Periods indicate unchanged residues, and parentheses indicate 
locations in which amino acids have been inserted, not substituted.
increased to 1 hr. Preparation of lysates and immunopré­
cipitation of A1PI was as described above. Protein con­
centrations were determined using the Bio-Rad DC pro­
tein assay (Bio-Rad). A1PÎ activities were calculated as 
A1 PI phosphorimager counts//ig protein Input into immu­
noprécipitation and the ratios of A1 PI synthesized in the 
presence and absence of hygromycin B were deter­
mined. When indicated, this value was adjusted to 1.0 
for cells expressing A1PI alone with no 2B protein, and 
the ratios for cells transfected with wild-type and mutant 
2B proteins were normalized.
RESULTS
The finding that poliovirus 2B protein inhibited trans­
port through the cellular secretory pathway and in­
creased plasma membrane permeability to hygromycin 
B in the absence of other viral proteins (Doedens and 
Kirkegaard, 1995) led us to ask (I) whether this function 
is conserved among other enteroviral 2B proteins and 
(ii) which structural protein domains are involved In these
activities. We chose to test CBV3 protein 2B because the 
phenotypes of viruses containing a number of different 
mutations in each of two hydrophobic domains of this 
protein (Fig. 1) have been recently characterized (van 
Kuppeveld et ai, 1995, 1996a).
Inhibition of protein secretion by coxsackie B3 virus
protein 2B
The CBV3 2B coding region was inserted into a dicis- 
tronlc plasmid designed to express both a single viral 
protein and human A1PI, a secreted protein. The pre­
dicted mRNA from the dicistronic plasmids is diagramed 
in Fig. 2A. Because A1P1 Is not expressed in untrans­
fected COS-1 cells, secretion of A1PI produced from di­
cistronic mRNAs can be used to measure effects of the 
coexpressed viral proteins on secretory pathway function 
(Doedens and Kirkegaard, 1995). COS-1 cells were trans­
fected with plasmids that encoded poliovirus protein 2B,
CBV3 protein 2E, or no viral protein in the first cistron, 
and secretion of the A1PI encoded in the second cistron 
was assayed in a pulse-chase experiment (Fig. 2B).
In cells that expressed only At PI, A1PI secretion can 
be observed boti from the observation that most of the 
labeled protein was found in the medium after a 2-hr
A
2B PV 5'NC A1PI
B
sample
PV 2BA1PI only _ 
med cells med cells med cells
CBV3 2B
b v#* V*
>' '
relative A1PI 
secretion 1.00 0.36 0.59
FIG. 2. Effect of expression of CBV3 2B protein on secretion of A1 PI. 
(A) Predicted dicistronic mRNA for coexpression of 2B proteins and 
A1PL Translation of A PI in the second cistron is driven by the internal 
ribosome entry site (HIES) element within the poliovirus 5'-noncoding 
region (PV5'NC). (B) C DS-1 cells were transfected with dicistronic plas­
mids containing the in jicated 2B coding region as the first cistron and 
A1PI sequence as thn second. Two days posttransfection, the cells 
were radiolabeled wiih [35S]methionine for 30 min and chased with 
unlabeled methionine for 2 hr. At the end of the chase period, culture 
supernatants and cell ysates were harvested and A1 PI in each sample 
was quantified by imnunoprecipitation followed by SDS-PAGE and 
phosphorimager analysis. The phosphorimage shows radiolabeled 
A1PI immunoprecipita ed from culture medium (med) and cell lysates 
(cells) derived from cel s transfected with the indicated constructs. The 
relative fraction of labeled A1PI secreted into the medium within the 
chase period is indtca ed below each pair of lanes; this normalization 
eliminates any differences in transfection efficiency between experi­
ments. The difference in migration between the intracellular and se­
creted forms of A1PI reflects Incomplete glycosylation of the intracellu­
lar material (Doedens snd Kirkegaard, 1995).
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chase and from the shift in electrophoretic mobility that 
resulted from modification of N-linked oligosaccharides 
on A1 Pi within the secretory pathway, in cells transfected 
with the plasmid that expresses poliovirus protein 2B as 
well as A1PI, only 36% of the amount of radiolabeled 
A1PI was released into the culture medium in the 2-hr 
chase period. Similarly, the expression of CBV3 protein 
2B reduced secretion of A1PI to 59% of the control (Fig. 
2B). The lower level of inhibition of A1PI secretion by 
CBV3 protein 2B may reflect either a lesser ability of this 
protein to inhibit secretory pathway function or a lower 
level of expression. Nevertheless, the ability of CBV3 
protein 2B to inhibit A1PI secretion indicates that this 
activity is conserved among these two enteroviruses.
Coxsackie B3 virus protein 2B increases the 
sensitivity of cellular translation to hygromycin B
Hygromycin B is an inhibitor of translation to which 
mammalian cells are ordinarily relatively insensitive, be­
cause the compound enters cells poorly. Increased sen­
sitivity of translation to hygromycin B has been demon­
strated in cells infected with poliovirus and several other 
viruses (Benedetto et ai., 1980; Munoz and Carrasco, 
1981, 1983; Munoz et ai, 1985). In poliovirus-infected 
cells, this increased sensitivity correlates with increased 
efflux of 86Rb (Lopez-Rivas et ai., 1987) and is thus 
thought to reflect increased permeability of the cellular 
plasma membrane to the drug. In addition, Escherichia 
coii that express poliovirus protein 2B show increased 
uptake of ONPG, increased efflux of [3H]uridine, and in­
creased sensitivity to hygromycin B (Lama and Carrasco, 
1992), further suggesting that this protein can signifi­
cantly alter membrane permeability and that these 
changes can be detected as increased sensitivity of 
translation to hygromycin B.
To determine whether expression of CBV3 protein 2B 
also increases sensitivity to hygromycin B, we measured 
the effect of hygromycin B on A1PI expression in trans­
fected COS-1 cells (Fig. 3). In cells expressing no viral 
protein, hygromycin B had very little effect on A1 PI accu­
mulation in a 1 -hr labeling period, indicating that the 
cellular membranes were relatively impermeable to this 
inhibitor. In contrast, expression of either poliovirus or 
CBV3 protein 2B increased sensitivity to hygromycin B 
considerably. A1 PI synthesis was reduced approximately 
threefold by hygromycin B in cells expressing either 2B 
protein, arguing that both proteins are capable of modi- 
fying membrane permeability.
Effects of mutations in the amphipathic helix motif on 
secretion inhibition and hygromycin B sensitivity
To investigate the contribution of the putative cationic 
amphipathic a-helix motif that comprises residues 37 to 
54 of CBV3 protein 2B to secretion inhibition and hygro­
mycin B sensitivity, several mutant alleles of CBV3 2B
A
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FIG. 3. Effect of expression of CBV3 protein on hygromycin B perme­
ability. COS-1 cells were transfected with dicistronic plasmids con­
taining the indicated 2B coding region as the first cistron and A1PI 
sequence as the second cistron. Two days posttransfection, hygro­
mycin B sensitivity was assayed, (A) Phosphorimage of immunoprecipi- 
tated A1PI synthesized in the presence and absence of 0.5 mg/ml 
hygromycin B as indicated; results from duplicate plates are shown. 
The bracketed pair of lanes for the CBV3 2B samples represents a 
single sample inadvertently divided between two lanes of the gel. (B) 
Quantitation of relative hygromycin B sensitivity for samples shown in 
(A); black and grey bars represent duplicate samples. A1 Pl-specific 
phosphorimager counts from (A) were normalized to the total protein 
input into the immunoprécipitation reactions. The ratio of protein accu­
mulation in the presence and absence of hygromycin B is shown.
with amino acid changes within this domain (van Kuppe- 
veld et ai., 1996a) were cloned into the dicistronic A1PI 
expression plasmid. The amino acid changes of five mu­
tations within this domain are shown in Fig. 1. Plasmids 
that encoded wild-type and mutant CBV3 2B proteins 
were transfected into COS-1 cells and assayed for the 
ability of the expressed mutant 2B proteins to inhibit A1 PI 
secretion and to increase sensitivity to hygromycin B 
(Fig. 4).
All mutant 2B proteins could still inhibit protein secre­
tion and increase the permeability of cells to hygromycin 
B. However, the ability of the mutant proteins to induce 
these alterations varied for the different mutations. The 
relative effects on virus viability (Fig. 4) and on the two 
different biochemical activities correlated well for the in­
dividual mutant proteins. Each of the mutations K[41, 44, 
48]E, ins[41]L, and ins[44]L, which eliminated viral viabil­
ity, reduced the ability to inhibit protein secretion and 
modify plasma membrane permeability to a greater ex- 
tentthandid mutations K[41]L and K[41,44]L, which gave 
rise to viable, but slow-growing, viruses. Thus, mutant 
proteins that were the most defective in the virus were 
the least effective in secretion inhibition and also the
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Designation Virus growth'
Amohipathic Helix
no viral proteins
wild type CBV3 2B
2B-K[41,44,48]E
2B-K[41]L
2B-K[41,44]L
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FIG. 4. The effects of mutations in the putative cationic amphipathic a-hellx and the second hydrophobic domain of CBV3 protein 28 on viral 
growth in a single-cycle infection, inhibition of protein secretion, and increase in susceptibility to hygromycin B. QViral titer after 8 hr growth (van 
Kuppeveld et a i, 1995, 1996a). ^Ability of mutant CBV3 2B proteins to inhibit protein secretion, expressed as the percentage of the effect of wild- 
type 2B protein. COS-1 cells were transfected with dicistronic plasmids encoding the indicated viral protein as the first cistron and A 1 Pi secretion. 
Values calculated for cells transfected with wild-type CBV3 2B were normalized to 100% inhibition. Values for cells expressing A1PI alone with no 
2B protein were adjusted to 0% inhibition. Error bars represent standard deviations of measured values. cAbility of mutant CBV3 2B proteins to 
increase hygromycin B sensitivity, expressed as the percentage of the effect of wild-type 2B protein. COS-1 cells were transfected with dicistronic 
plasmids encoding the indicated viral protein as the first cistron and A1P1 as the second cistron. At 2 days posttransfection, transfected cells were 
assayed for hygromycin B sensitivity. Values calculated for cells transfected with wild-type CBV3 2B were normalized to 100% increase in hygromycin 
B sensitivity. Values calculated for cells expressing A1PI alone with no 2B protein were adjusted to 0% increase. Error bars represent standard 
deviations of measured values.
least effective in increasing ceil sensitivity to hygromycin 
B. Furthermore, mutations in this domain showed that 
the integrity of this domain is important for both the inhibi­
tion of protein secretion and the increase in membrane 
permeability caused by CBV3 protein 2B.
Effects of mutations in the second hydrophobic 
domain on secretion inhibition and hygromycin B 
sensitivity
We next tested the effects of mutations in the second 
hydrophobic domain of CBV3 protein 2B on the two activi­
ties (Fig. 1; van Kuppeveld et aL, 1995). Little correlation 
between the relative effects of these mutations on the 
inhibition of protein secretion and the increase in mem­
brane permeability was observed (Fig. 4). With the excep­
tion of mutation l[64]SA/[66]S, little effect on the ability 
of CBV3 2B to increase hygromycin B susceptibility was 
observed for any of the mutations in the second hy­
drophobic domain. Nevertheless, mutations C[75]M and 
S[77]M/C[75]M impaired the ability of protein 2B to inhibit 
protein secretion. Thus, the observed inhibition of protein 
secretion by CBV3 protein 2B is probably not caused by 
the increase in membrane permeability.
Virus containing mutations S[77]M/C[75]V arose due to 
a reversion mutation in RNAs carrying mutations S[77]M/ 
C[75]Mr which destroy viral viability. Mutant 2B protein 
that contained these S[77]M/C[75]V mutations exhibited 
wild-type activity in both biochemical assays, although 
virus carrying the mutant 2B protein showed reduced 
growth compared to wild-type virus (Fig. 4). Similarly, 
virus that contained mutation A[71 ] E was nonviable, al­
though the 2B protein carrying this mutation showed 
nearly wild-type ability both to inhibit protein secretion 
and to increase the susceptibility of cells to hygromycin 
B. These observations argue that protein 2B has other 
functions in the viral infectious cycle in addition to those 
we have assayed here.
DISCUSSION
Mutations in the 2B proteins of both poliovirus and cox­
sackievirus give rise to viruses with primary defects in RNA 
synthesis (Johnson and Sarnow, 1991; Li and Baltimore, 
1988; van Kuppeveld etaL, 1995,1996a). However, no bio­
chemical activity directly tied to viral genome replication 
has yet been demonstrated for 2B. The only activities identi-
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aqueous channel
membrane
cytosol
FIG. 5. Potential topologies of protein 2B, Putative multimers of 2B that allow the formation of an aqueous channel are shown on the left. Helices 
representing the membrane-integral amphipathic a-helix (nearer the NHg-terminus) and the second hydrophobic domain (nearer the COOH-terminus) 
are shown. The hydrophilic face of the cationic a-helix is darkly shaded. An alternative model is shown on the right, in which the hydrophobic face 
of the «-helix perturbs the membrane while lying parallel to It.
tied for protein 2B in eukaryotic cells are the two tested 
here: the inhibition of protein secretion and modification of 
the plasma membrane permeability. In this study, we have 
shown that coxsackie B3 virus protein 2B displays these 
two activities (Figs. 2 and 3), as previously demonstrated 
for poliovirus protein 2B (Doedens and Kirkegaard, 1995).
It was possible either that secretion inhibition and 
plasma membrane modification were two separate func­
tions of protein 2B or that one of these effects was the 
consequence of the other. For example, permeabilization 
of the plasma membrane by 2B could cause the inhibition 
of protein secretion by altering the intracellular ionic milieu; 
increased intracellular calcium levels and changes in con­
centrations of monovalent cations have been documented 
in poliovirus-infected cells (Carrasco etaL, 1993; Irurzun et 
al, 1995a; Lopez-Rivas et ai, 1987). Such changes might 
affect a number of cellular processes, including secretory 
transport. Alternatively, if the direct effect of 2B were on 
protein transport, the protein and lipid composition of the 
plasma membrane could be altered, resulting in altered 
permeability.
Analysis of mutations in CBV3 protein 2B has helped to 
clarify the relationship between secretion inhibition and 
membrane permeabilization. Experiments examining muta­
tions in the second hydrophobic domain of CBV3 2B (Fig. 4) 
suggest that the two activities are separable. In particular, 
mutations C[75]M and S[77]M/C[75]M showed effects on 
membrane permeabilization similar to wild-type CBV3 2B, 
but less effective inhibition of protein secretion than the 
wild-type protein. Therefore, plasma membrane permeabili­
zation, as measured by hygromycin B sensitivity, is insuffi­
cient to explain the secretion inhibition displayed by wild- 
type 2B. Other mutations in the second hydrophobic domain 
and those in the amphipathic helix motif affected permeabil­
ity to hygromycin B and secretion inhibition to a similar 
extent (Fig. 4). The correlation between the two assays
may result from losses in activity stemming from general 
disruption of 2B structure, a role for the cationic amphi­
pathic helix in both functions, or both.
Does either the ability to inhibit protein secretion or 
the ability to modify plasma membrane permeability cor­
relate well with the phenotype displayed by CBV3 2B 
mutant viruses (Fig. 4)? The data are inconclusive on 
this point. Protein 2B carrying mutations S[77]M/C[75]M, 
which rendered the virus nonviable, showed a wild-type 
ability to increase hygromycin B sensitivity but an im­
paired ability to inhibit protein secretion. A revertant of 
this mutant, which contained a Met to Val substitution to 
yield 2B protein S[77]M/C[75]V, also showed wild-type 
ability to increase hygromycin B sensitivity but increased 
the ability of the mutant 2B protein to inhibit protein se­
cretion. Thus, a reversion from nonviability to viability 
correlated with an increase in ability to inhibit protein 
secretion. Although 2B protein carrying reversion muta­
tion S[77]M/C[75]V showed wild-type abilities in inhibi­
tion of protein secretion and increasing hygromycin B 
sensitivity, viruses carrying this protein exhibited an im­
paired virus growth. Mutation A[71]E, which rendered 2B 
able to inhibit protein secretion comparably to wild-type 
CBV3 2B and which caused only a slight reduction in 
the ability to induce membrane permeabilization, even 
completely abrogated vRNA replication and virus growth 
(Fig. 4). These observations point to roles for viral protein 
2B in the viral replicative cycle otfierthan the interactions 
with host cell membranes studies here. Consistent with 
this, mutant poliovirus 2B proteins defective in vRNA syn­
thesis due to mutations outside eitherthe cationic amphi­
pathic oi-helical domain or the second hydrophobic do­
main (mutations 2B201 and 2B204 at residue 29; Johnson 
and Sarnow, 1991) exhibited wild-type activities in inhib­
iting cellular protein secretion (Doedens, 1996).
The organization and structure of the cationic amphi-
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pathic a-helix in enterovirus protein 2B is similar to that 
of "lytic" polypeptides, a group of cationic amphipathic 
a-heiical peptides that exert cytolytic effects on mem­
branes (Segrest etal., 1990), Two models of action have 
been proposed to explain the cytolytic action of these 
peptides. In one model, the cationic peptides form aque­
ous channels by traversing the membrane and forming 
multimers that expose their hydrophobic sides to the lipid 
bilayer and their hydrophilic faces to the aqueous pore. 
In a second model, the peptides perturb the membrane 
by lying parallel to the membrane, with their hydrophobic 
side inserted in the lipid bilayer, thereby making the 
phospholipids more susceptible to the action of phos- 
pholipases (Bernheimer and Rudy, 1986). Two putative 
structural models of 28 that are consistent with the need 
for processing at the 2A/2B and 2B/2C cleavage sites by 
protein 3Cpro, a cytosolic protein, are shown in Fig. 5.
The increase in sensitivity to hygromycin B caused by 
expression of CBV3 protein 2B is sensitive to mutations 
in the predicted cationic amphipathic a-helix. Cationic 
amphipathic a-helical peptides can form voltage gated 
and cation-selective channels in lipid bilayers (Agawa et 
aL, 1991; Argiolas and Pisano, 1985; Ide et a l , 1989; 
Tosteston et ai, 1989). It is tempting to speculate that 
channels formed by multimeric 2B proteins are responsi­
ble for the influx of the sodium ions, the efflux of potas­
sium ions, and the alterations in calcium levels that are 
observed from the third hour postinfection by poliovirus 
(Carrasco et ai, 1993; Irurzun et al., 1995a). Alterations 
in ionic milieu have been implicated in the shut-off of 
host cell translation, as high concentrations of sodium 
ions are inhibitory to host cell but not to viral translation 
(Carrasco and Smith, 1976), and the cleavage of the p220 
component of initiation factor e¡F-4F may not be sufficient 
for complete inhibition of host cell protein synthesis 
(Bonneau and Sonenberg, 1987; Irurzun et ai., 1995b; 
Pérez and Carrasco, 1992). Consistent with this, coxsack­
ieviruses that produce reduced levels of 2B protein due 
to the presence of poorly processed 2B/2C cleavage 
sites, failed to completely inhibit host cell protein synthe­
sis (van Kuppeveld et al., 1996b). Modifications in mem­
brane permeability may also be required for cell lysis, 
release of progeny virus, or both.
Inhibition of cellular protein secretion by viral protein 
2B requires both the cationic amphipathic helix and ihe 
hydrophobic domain, and is not a direct result of in­
creased membrane permeability. The inhibition of protein 
secretion during enterovirus infection is likely to result 
from alteration or sequestration of membranes or pro­
teins required for secretory transport. This could simply 
be a consequence of RNA replication complex assembly, 
or it may play an additional role in viral amplification 
such as blocking host antiviral responses (Doedens and 
Kirkegaard, 1995). The exact functions of protein 2B in 
both membrane permeabilization and inhibition of protein 
secretion await further investigation.
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